Hedge funds typically have a reputation for being tight-lipped about their investing moves, rarely offering much insight to retail investors. However, once every quarter, institutional money managers are required to file a form 13F with the Securities and Exchange Commission (SEC) — a document that essentially outlines all of the stocks their funds bought or sold during the previous quarter, and their holdings at the end of it.
Citadel Advisors, run by billionaire investor Ken Griffin, is one of the most prestigious hedge funds on Wall Street, and while reviewing the 13F it filed on Nov. 14, I noticed something. In the third quarter, the fund increased its stake by 172% in a semiconductor stock that isn’t Nvidia.
Are You Missing The Morning Scoop? Wake up with Breakfast news in your inbox every market day. Sign Up For Free »
Should retail investors follow Griffin’s lead, or would they be better off staying on the sidelines?
During the third quarter, Citadel significantly increased its position in Intel (NASDAQ: INTC). The table below illustrates Citadel’s stakes in Intel as of the ends of the last five quarters.
Metric |
Q3 2023 |
Q4 2023 |
Q1 2024 |
Q2 2024 |
Q3 2024 |
---|---|---|---|---|---|
Intel shares owned (in millions) |
3.8 |
3.7 |
5.4 |
6.8 |
18.5 |
Data source: Hedge Follow
As the data above shows, Citadel has been scooping up the chipmaker’s shares during the last three quarters. What’s curious, however, is the company’s purchase of 11.7 million shares over the last three months, nearly tripling its stake.
It’s well-known that one of President-elect Donald Trump’s primary campaign themes was his support for investing more into American-made products and domestic manufacturing. That said, Trump hasn’t exactly endorsed President Biden’s CHIPS Act — which will put $280 billion worth of government support behind growing the country’s semiconductor manufacturing capacity — with a glowing review.
Nevertheless, I personally don’t think Trump will try to change the CHIPS Act too much after he assumes office in January. At the end of the day, the CHIPS Act is doing precisely what Trump wants — incentivizing semiconductor businesses to expand their manufacturing capabilities in the U.S.
And perhaps no other U.S.-based chipmaker has benefited from the CHIPS Act more than Intel. In my opinion, Intel is also well positioned to receive even more business from the federal government over the next four years.
As of the time of this writing, shares of Intel are down by more than 50% this year. I tend to see the narrative surrounding Intel as being “one step forward, two steps backward.” Over the last several years, the company has lost significant market share to competitors, and it hasn’t exactly been impressing potential partners with its foundry process. Most recently, Intel was replaced in the Dow Jones Industrial Average by Nvidia.